- Investing Ideas
- Pakistani Pharmaceuticals & Biotech Sustainable Track Record
Pakistani Pharmaceuticals & Biotech Sustainable Track Record
Results
5
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
5 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨110.2b
A biopharma company, engages in the discovery, development, and delivery of medicines and vaccines in Pakistan.
GLAXO
PK₨345.96
7D
0.4%
1Y
-18.4%
Macter International
Market Cap: PK₨12.6b
A contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan.
MACTER
PK₨275.85
7D
-1.3%
1Y
-32.3%
Hoechst Pakistan
Market Cap: PK₨38.6b
Together with its subsidiary, manufactures, sells, and trades in pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,002.97
7D
0.5%
1Y
4.5%
AGP
Market Cap: PK₨49.8b
Operates as an independent pharmaceutical manufacturing company in Pakistan and Afghanistan.
AGP
PK₨177.94
7D
-5.6%
1Y
-15.3%
Highnoon Laboratories
Market Cap: PK₨52.3b
Together with its subsidiary, engages in the development, production, marketing, and distribution of pharmaceutical and allied consumer products in Pakistan, Afghanistan, the United Arab Emirates, Sri Lanka, France, Sudan, Cambodia, Kenya, Iraq, Dubai, Tanzania, and internationally.
HINOON
PK₨987.43
7D
-1.6%
1Y
-18.9%